|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | -.--% |
| 2023 | Public Joint-Stock Company "Pharmsynthez" Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Public Joint-Stock Company "Pharmsynthez" Auditor Raises 'Going Concern' Doubt | CI |
Public Joint-Stock Company "Pharmsynthez" reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was RUB 172.46 million compared to RUB 207.96 million a year ago. Net loss was RUB 163.61 million compared to RUB 67.45 million a year ago.
Basic loss per share from continuing operations was RUB 0.54 compared to RUB 0.22 a year ago. Diluted loss per share from continuing operations was RUB 0.54 compared to RUB 0.22 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 15.5M | |
| +55.19% | 815B | |
| +45.57% | 654B | |
| -6.09% | 354B | |
| +21.92% | 337B | |
| +19.47% | 247B | |
| +3.68% | 229B | |
| +14.08% | 219B | |
| +10.86% | 171B | |
| -2.78% | 159B |
PHARMSYNTHEZ 
